G. MATHE, M. SCHNEIDER; JL. AMIEL; L. SCHWARZENBERG; A. CATTAN, [TRIAL TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH DIBROMOMANNITOL]., in Nouv Rev Fr Hematol, vol. 4, pp. 716-8, PMID 14199503.
DF. Chiuten, M. Rozencweig; DD. Von Hoff; FM. Muggia, Clinical trials with the hexitol derivatives in the U.S., in Cancer, vol. 47, n. 3, Feb 1981, pp. 442-51, PMID 6784907.
RT. Silver, R. Mick; R. Cooper; RR. Ellison; R. Levy; K. Brunner; JM. Schwartz; JF. Holland, A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B., in Cancer, vol. 60, n. 7, Oct 1987, pp. 1442-8, PMID 3113712.
E. Kelemen, S. Tura; T. Burger, Decreasing risk of leukaemia during prolonged follow-up after mitobronitol therapy for polycythaemia vera., in Lancet, vol. 2, n. 8559, Sep 1987, p. 625, PMID 2887907.
E. Kelemen, S. Tura, Mitobronitol: an alkylating agent that does not induce extra leukemia cases if applied as pulse therapy for polycythemia vera., in Ann N Y Acad Sci, vol. 459, 1985, p. 335, PMID 3938195.
E. Kelemen, [Short-term massive myelobromol therapy in polycythemia vera: a 12-years' experience. Model for a clinical trial of cytostatic drugs]., in Orv Hetil, vol. 124, n. 1, Jan 1983, pp. 3-13, PMID 6402751.
H. Yonemitsu, S. Kanazawa; H. Kondo; K. Yamaguchi; K. Okuda; H. Shigeta, [Treatment of polycythemia vera with dibromomannitol (author's transl)]., in Rinsho Ketsueki, vol. 21, n. 5, maggio 1980, pp. 587-91, PMID 6774132.
NF. Klimova, [10-years experience with myelobromol treatment of myelofibrosis]., in Haematologia (Budap), vol. 11, n. 1-2, 1977, pp. 57-72, PMID 615089.
K. Kitajima, [Problems on the treatment of chronic myelogenous leukemia (CML)--from the point of the blast crisis (author's transl)]., in Rinsho Ketsueki, vol. 19, n. 4, Apr 1978, pp. 386-91, PMID 279725.
